Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10621	Companies
225706	Keywords
154266	Articles
119431	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 million. Agreement includes upfront and milestones payments, double-digit royalties, and collaboration on manufacturing and clinical development

Biophytis Latin America Exclusive Rights Blanver Pharmaceutical Deal
PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€. Accord de licence exclusive pour la commercialisation de BIO101, y compris dans l’obésité et les infections respiratoires

Biophytis Accord BIO101 Blanver Am\u00e9rique Latine
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years ago

Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€

Biophytis Amérique Latine Accord De Licence BIO101 Blanver
REGULATED PRESS RELEASE

published on 06/20/2024 at 07:00, 2 years ago

Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million. Collaboration for commercialization and clinical development announced

Biophytis Latin America BIO101 Exclusive Rights Blanver
BRIEF

published on 06/20/2024 at 01:15, 2 years ago

Biophytis prolonge son contrat avec Atlas pour financer ses activités cliniques

Biophytis Biotechnologie Financement Obligations Convertibles Atlas
BRIEF

published on 06/20/2024 at 01:15, 2 years ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
PRESS RELEASE

published on 06/20/2024 at 01:10, 2 years ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA

Contrat Biophytis Financement Atlas OBA
PRESS RELEASE

published on 06/20/2024 at 01:10, 2 years ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors
BRIEF

published on 06/19/2024 at 23:05, 2 years ago

Biophytis prolonge son contrat avec Atlas pour le financement de ses activités

Biophytis Biotechnologie Financement ORNANE Atlas
BRIEF

published on 06/19/2024 at 23:05, 2 years ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas

Accesswire

Published on 06/24/2026 at 03:15, 2 hours 43 minutes ago

Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 5 hours 58 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 6 hours 13 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 6 hours 38 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 6 hours 43 minutes ago

EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 04:00, 1 hour 57 minutes ago

Shipping edges closer to onboard carbon mineralisation as IMO endorses Shanghai Qiyao Technology Group Co., Ltd. proposals
Published on 06/24/2026 at 02:05, 3 hours 52 minutes ago

FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Published on 06/23/2026 at 22:20, 7 hours 37 minutes ago

Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 9 hours 42 minutes ago

EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:59, 10 hours 58 minutes ago

Holding(s) in Company

Les Echos

Published on 06/23/2026 at 19:47, 10 hours 10 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 10 hours 10 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 10 hours 47 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 10 hours 47 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 11 hours 25 minutes ago

Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix

View all LES ECHOS COMFI WIRE